Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.
about
Symptom management in the older adult: 2015 updateHow should we manage information needs, family anxiety, depression, and breathlessness for those affected by advanced disease: development of a Clinical Decision Support Tool using a Delphi design.Prescribing practices in hospice patients with adult failure to thrive or debility.The dopamine dilemma: using stimulants and antipsychotics concurrently.Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review.Wake-promoting pharmacotherapy for psychiatric disorders.Attention enhancing effects of methylphenidate are age-dependent.Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one casesRoyal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Palliative care psychiatry: update on an emerging dimension of psychiatric practice.Research priorities in geriatric palliative care: nonpain symptoms.Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants.Therapeutic armamentarium for treating depression.Fatigue in Parkinson's disease.The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder.Antidepressant drug development: Focus on triple monoamine reuptake inhibition.Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.The Frailty Phenotype and Palliative Care Needs of Older Survivors of Critical Illness.Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities.Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.Randomized, double-blind, placebo-controlled study of methylphenidate for the treatment of depression in SSRI-treated cancer patients receiving palliative care.Behavioral phenotype in the 9q subtelomeric deletion syndrome: a report about two adult patients.Use of attention-deficit/hyperactivity disorder medication among older adults in Denmark.Patterns and profiles of Methylphenidate use in both children and adults.
P2860
Q30374202-E52276FD-123A-4CE6-A7B1-A8FFE275318FQ30668504-9C5470AE-AA2F-4A25-AA05-C1F4799912D8Q33699930-F87D5E04-0342-4BB3-B25E-3E4FCC43AFB5Q33969132-429534E6-5A10-4CC3-A3E7-01F8DB3B9BC7Q34280107-87320240-85A6-4128-A3BF-AB5936F77471Q34443394-54B34174-AC1A-4E56-80CB-D849BA4B6F0CQ34902438-E0E79190-0747-473F-99E8-E4C57E308EF0Q35020147-183097FA-1E5C-43F5-91D5-987A96893933Q35862776-1082CFA9-7F6E-4933-9B64-74147EDE1202Q37145934-2ADF1EBF-D9F6-480A-9CDD-82BF38F5A5BDQ37280693-7FC620A6-DECF-4F2C-9C6A-5264056E8B48Q37700662-14AE9AAE-721B-447E-B5AD-883C793867D8Q37777008-A1F8FD7E-C7C2-4DE2-BE68-0092A7665B32Q37884077-9EB2F24B-0EDF-4D0B-A28B-FF48AF76A06AQ38027452-98B83098-5F4D-478E-9BDC-F14F5CB3D692Q38214174-D6A63F78-9B52-4F39-BD45-0374C40A3DACQ38260259-F746B75F-F0F4-4F55-8264-89D6D77C65BFQ38476909-3FC74F44-915D-4759-A0B1-E43185D1FD3BQ38927263-573FE845-CBEF-4787-88CE-27A20664520AQ39427310-5628F7BB-3A58-4421-921A-A88DF1725114Q47098182-0DC0C055-389A-41B6-BD8D-389A088B7752Q47980229-13C96621-9E21-4F35-BA57-0482A3DB8B22Q48393217-B9D14D2C-B665-47FB-9431-7C877F6371A5Q50578046-409EC96D-2856-4EBB-AE5F-7CC8C6E268CBQ51411756-7FE15122-9431-4464-BEC9-1F61F3DD8FB0
P2860
Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Methylphenidate for the treatm ...... lts and terminally ill adults.
@ast
Methylphenidate for the treatm ...... lts and terminally ill adults.
@en
Methylphenidate for the treatm ...... lts and terminally ill adults.
@nl
type
label
Methylphenidate for the treatm ...... lts and terminally ill adults.
@ast
Methylphenidate for the treatm ...... lts and terminally ill adults.
@en
Methylphenidate for the treatm ...... lts and terminally ill adults.
@nl
prefLabel
Methylphenidate for the treatm ...... lts and terminally ill adults.
@ast
Methylphenidate for the treatm ...... lts and terminally ill adults.
@en
Methylphenidate for the treatm ...... lts and terminally ill adults.
@nl
P2860
P1476
Methylphenidate for the treatm ...... lts and terminally ill adults.
@en
P2093
Susan E Hardy
P2860
P356
10.1016/J.AMJOPHARM.2009.02.006
P577
2009-02-01T00:00:00Z